This document summarizes a workshop on patient safety hosted by the European Patients' Forum (EPF). It defines key terms like patient safety, medical errors, and system failures. It outlines the EU legislative framework and opportunities for patient involvement. Survey results from EPF members showed low awareness of recommendations but a role for patient organizations in developing safety information. Members saw informing citizens, prioritizing safety, and involving patients and health professionals as important to better implement recommendations.
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
Is HTA purely technical?
drivers for patient involvement in HTA
patient participation or tokenism
medicines do not reach patients due to delays in HTA evaluation
need for harmonized HTA
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
Patients should be involved in HTA process to assure a robust process that embraces patients' needs, preferences, perspectives. ECPC-European Cancer Patient Coalition leverages on European Institutions for a solution to the timely authorization and reimbursement of innovative cancer medicines
Is there patient involvement in HTA? Can patients influence HTA decision making?Kathi Apostolidis
Is HTA purely technical?
drivers for patient involvement in HTA
patient participation or tokenism
medicines do not reach patients due to delays in HTA evaluation
need for harmonized HTA
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
Patients should be involved in HTA process to assure a robust process that embraces patients' needs, preferences, perspectives. ECPC-European Cancer Patient Coalition leverages on European Institutions for a solution to the timely authorization and reimbursement of innovative cancer medicines
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
"How Patient (Advocates) discuss Clinical Research on the Internet", presented by Jan Geissler (Twitter @jangeissler) at DIA Clinical Forum in The Hague on 9 Oct 2012.
The ESMO-ECPC Cancer Survivorship Guide and Cancer Survivorship Plan is a unique care and cancer advocacy tool.
Cancer patient advocates can include it in their work.
Innovations and Trends in Health Care: The Advent and Use of Personal Health ...Mark Silverberg
My semester-long research project in HSCI 2109 is about the advent and use of a very interesting innovation in health care: the Personal Health Record). This presentation is a mid-semester check-in with my fellow students to educate them about some key definitions, stakeholders, barriers, and recommendations I have gathered around system development and implementation of PHRs.
This is a topic I am very interested and invested in so I would be happy to discuss it with anyone who is interested!
Workshop 6 - Brainstorming
& Policy Development session:
Training, information and education of MDs
"Case study: Italian Training for MDs,"
Renza Galluppi, UNIAMO, Italy
Patients for patient safety. Margaret Murphy. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
Presentation in the framework of the International Conference "10th anniversary of the Spanish Network of Health Technology Assessment Agencies. Towads patient and public engagement in HTA" Zaragoza 27-28 April 2017
Jan Geissler - How Patient (Advocates) discuss Clinical Research on the Internetpatvocates
"How Patient (Advocates) discuss Clinical Research on the Internet", presented by Jan Geissler (Twitter @jangeissler) at DIA Clinical Forum in The Hague on 9 Oct 2012.
The ESMO-ECPC Cancer Survivorship Guide and Cancer Survivorship Plan is a unique care and cancer advocacy tool.
Cancer patient advocates can include it in their work.
Innovations and Trends in Health Care: The Advent and Use of Personal Health ...Mark Silverberg
My semester-long research project in HSCI 2109 is about the advent and use of a very interesting innovation in health care: the Personal Health Record). This presentation is a mid-semester check-in with my fellow students to educate them about some key definitions, stakeholders, barriers, and recommendations I have gathered around system development and implementation of PHRs.
This is a topic I am very interested and invested in so I would be happy to discuss it with anyone who is interested!
Workshop 6 - Brainstorming
& Policy Development session:
Training, information and education of MDs
"Case study: Italian Training for MDs,"
Renza Galluppi, UNIAMO, Italy
Patients for patient safety. Margaret Murphy. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
Robert Francis presents the lessons from his inquiry into care failings at Mid Staffordshire NHS Foundation Trust. These are the slides from his talk at The King's Fund conference on 27 February 2013.
Safety is Personal: Partnering with Patients and Families for the Safest CareEngagingPatients
The work of NPSF"s Lucian Leape Institute's Roundtable on Consumer Engagement, "Safety Is Personal: Partnering with Patients and Families for the Safest Care" is a call to action for health leaders, clinicians, and policy makers to take the necessary steps to ensure patient and family engagement at all levels of health care.The report identifies specific action items for health leaders, clinicians, and policy makers to pursue in making patient and family engagement a core value in the provision of health. care.
Joint Commission and Patients for Patient Safety. Laura Botwinick. III International Conference on Patient Safety: "Patients for Patient Safety" (Madrid, Ministry of Health and Consumer Affairs, 2007)
Canadian healthcare organizations are taking patient and family engagement to new heights and the best of the best want to share the secrets of their success with you!
5 Ways Healthcare Organizations Can Promote Patient SafetyAKW Medical
Patients and healthcare professionals can work together to improve patient safety to ensure a higher quality of care, reduce medical errors, and refocus on supporting good health and well-being.
XAPI and Machine Learning for Patient / LearnerJessie Chuang
xAPI and Machine Learning can help us build "intelligent assistance" for patients and learners, but human-in-the-loop machine learning is important. We need good learning design from the beginning and as we return data to instructors and learners immediately, humans can give great inputs to this human-machine collaboration.
Geneva Pharma Forum on Pharmacovigilance: Partnering for
Patient Safety (Geneva, 20 November 2012), Jeremiah Mwangi, Director, Policy and External Affairs, IAPO
Patient empowerment at EU level - Katja Neubauer, Deputy Head of Unit, Healthcare Systems Unit, DG Sanco for the 8th European Patients' Rights Day in Brussels, May 12th 2014
In the presentation, a summary of initiatives to be taken by hospitals in different areas for patient safety have been described for the knowledge, practices and implementation of patient safety initiative by hospital managers/Administrators.
A Trust-Centric Healthcare Journey Part II | Full Presentation of PharmaLedge...PharmaLedger
In this presentation, you will find:
An introduction to the PharmaLedger project presented by Maria Eugenia (Xenia) Beltran | Project Coordinator / DRA and Use Case co-lead (Universidad Politécnica de Madrid)
Topic 1 | Clinical Trial eRecruitment | Despina Daliani (Onorach) and Ken Nessel (Pfizer)
Topic 2 | Clinical Trial eConsent | Hernando C. Giraldo (Boehringer Ingelheim) and Despina Daliani (Onorach)
Topic 3 | Health Data IoT Medical Device | Disa Lee Choun (UCB) and Francesca Rocchi (Bambino Gesù Children Hospital)
Topic 4 | Health Data Personalised Medicine | Beatriz Merino (Universidad Politécnica de Madrid) and Christos Kontogiorgis (Democritus University of Thrace)
You can also learn more about our #2 Open Webinar on Clinical Trials & Health Data by rewatching our video recording including the Q&A by clicking on the button below:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
EIT Health was established in 2015, as a ‘knowledge and innovation community’ (KIC) of the European Institute of Innovation and Technology (EIT). The EIT is made up of various KICs who each focus on a different sector, or area, of innovation – in our case, that is health and aging. The idea behind the EIT KICs is that innovation flourishes best when the right people are brought together to share expertise. The so called ‘knowledge triangle’, is the principle that when experts from business, research and education work together as one, an optimal environment for innovation is created.
https://eithealth.eu/
Tripartite dimension of interaction of patients, regulators and industry (Jan...jangeissler
Tripartite dimension of interaction of patients, regulators and industry, presented by Jan Geissler as a scene-setting presentation at the EUPATI Workshop on the interaction of patients, regulators and industry on 20 July 2016 in Berlin
Patient-centered pharmacovigilance represents a pivotal shift in the landscape of healthcare, emphasizing the active involvement of patients in the monitoring and reporting of adverse drug reactions. Unlike traditional pharmacovigilance, which primarily relies on healthcare professionals to identify and document adverse events, this approach recognizes patients as critical stakeholders in ensuring medication safety. By empowering patients to share their experiences, concerns, and observations regarding medication effects, whether positive or negative, healthcare systems can gain a comprehensive understanding of drug safety and efficacy in real-world settings. Patient-centered pharmacovigilance fosters a collaborative partnership between patients, healthcare providers, and regulatory agencies, promoting transparency, accountability, and ultimately, better patient outcomes. Through increased patient engagement and the utilization of patient-reported data, this approach enables healthcare systems to identify potential safety issues earlier, tailor treatment strategies to individual needs, and enhance overall drug safety surveillance efforts.
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015jangeissler
Overview and Status Quo of the European Patients Academy (EUPATI) project, presented by EUPATI Director Jan Geissler at the EMA Patient and Consumer Working Party (PCWP) meeting in London on 26 Nov 2015
Similar to Patients at the Centre of Patient Safety byEPF (20)
Kseniya Leshchenko: Shared development support service model as the way to ma...Lviv Startup Club
Kseniya Leshchenko: Shared development support service model as the way to make small projects with small budgets profitable for the company (UA)
Kyiv PMDay 2024 Summer
Website – www.pmday.org
Youtube – https://www.youtube.com/startuplviv
FB – https://www.facebook.com/pmdayconference
Enterprise Excellence is Inclusive Excellence.pdfKaiNexus
Enterprise excellence and inclusive excellence are closely linked, and real-world challenges have shown that both are essential to the success of any organization. To achieve enterprise excellence, organizations must focus on improving their operations and processes while creating an inclusive environment that engages everyone. In this interactive session, the facilitator will highlight commonly established business practices and how they limit our ability to engage everyone every day. More importantly, though, participants will likely gain increased awareness of what we can do differently to maximize enterprise excellence through deliberate inclusion.
What is Enterprise Excellence?
Enterprise Excellence is a holistic approach that's aimed at achieving world-class performance across all aspects of the organization.
What might I learn?
A way to engage all in creating Inclusive Excellence. Lessons from the US military and their parallels to the story of Harry Potter. How belt systems and CI teams can destroy inclusive practices. How leadership language invites people to the party. There are three things leaders can do to engage everyone every day: maximizing psychological safety to create environments where folks learn, contribute, and challenge the status quo.
Who might benefit? Anyone and everyone leading folks from the shop floor to top floor.
Dr. William Harvey is a seasoned Operations Leader with extensive experience in chemical processing, manufacturing, and operations management. At Michelman, he currently oversees multiple sites, leading teams in strategic planning and coaching/practicing continuous improvement. William is set to start his eighth year of teaching at the University of Cincinnati where he teaches marketing, finance, and management. William holds various certifications in change management, quality, leadership, operational excellence, team building, and DiSC, among others.
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
Cracking the Workplace Discipline Code Main.pptxWorkforce Group
Cultivating and maintaining discipline within teams is a critical differentiator for successful organisations.
Forward-thinking leaders and business managers understand the impact that discipline has on organisational success. A disciplined workforce operates with clarity, focus, and a shared understanding of expectations, ultimately driving better results, optimising productivity, and facilitating seamless collaboration.
Although discipline is not a one-size-fits-all approach, it can help create a work environment that encourages personal growth and accountability rather than solely relying on punitive measures.
In this deck, you will learn the significance of workplace discipline for organisational success. You’ll also learn
• Four (4) workplace discipline methods you should consider
• The best and most practical approach to implementing workplace discipline.
• Three (3) key tips to maintain a disciplined workplace.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
3.0 Project 2_ Developing My Brand Identity Kit.pptxtanyjahb
A personal brand exploration presentation summarizes an individual's unique qualities and goals, covering strengths, values, passions, and target audience. It helps individuals understand what makes them stand out, their desired image, and how they aim to achieve it.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
2. 1. What is patient safety?
2. Overview of the EU legislative framework and
opportunities for patients’ involvement
3. The patients’ role in patient safety
4. Part III: EPF member survey on the Council
Recommendation on patient safety
5. Conclusions & key messages
Overview
3. What is Patient Safety?
• “The absence of preventable harm to a patient during the
process of health care. (WHO)
• In simple terms: “When things go right, nothing bad happens.”
(NHS Scotland)
• (process or discipline of patient safety): “the coordinated efforts
to prevent harm, caused by the process of health care itself, from
occurring to patients” (WHO)
• “Patient safety incident”: any healthcare-related event that was
unintended, unexpected and undesired and which could have or
did cause harm to patients. (Incl. adverse events, near misses)
4. Some terminology (ii)
• “Harm”: a patient’s health or quality of life is negatively affected
by any aspect of their interaction with health care.
• Some incidents of harm are preventable, while others are
recognised as complications of care.
• Examples:
– allergic reaction to a medication
– incision made in the wrong place on a patient scheduled for surgery
• Severity and impact of unintentional harm can range from a brief
inconvenience to a prolonged hospitalisation, disabling injury or
even death.
Source: NHS Scotland, http://www.evidenceintopractice.scot.nhs.uk/patient-safety/what-is-patient-safety.aspx
5. Some terminology (iii)
• Errors vs violations:
• Error = unintentional action
– Example of incorrectly executed plans as a result of attention failure: an
anaesthesist wants to adjust the airflow to a patient but turns the wrong
dial.
– Example of a plan that is not executed: a GP forgets to issue her promised
prescription for a patient after finishing her other home visits.
– Example of the wrong plan: initial misdiagnosis and wrong treatment.
• Violation = deliberate action, including negligence , medical
malpractice.
– Example: deliberately inadequate record-keeping because you are “too
busy”
– Deviation from accepted standards of practice (by action or omission)Source: NHS Scotland, http://www.evidenceintopractice.scot.nhs.uk/patient-safety/what-is-patient-safety.aspx
6. System vs individual?
The “Swiss cheese model”
Serious patient safety incidents are usually caused by multiple
systems failures
- only rarely by frontline hcp errors
- But hcp must be vigilant for even seemingly unimportant errors
- Any incident even “trivial” can be learned from
Patient safety needs a system approach – building patient safety
culture in organisations, no-blame no-shame reporting and
learning systems
Source: NHS Scotland, http://www.evidenceintopractice.scot.nhs.uk/patient-safety/what-is-patient-safety.aspx
7. Why is Patient Safety important
WHO estimates:
• “As many as 1 in 10 patients is harmed” while receiving hospital
care in developed countries
• “At any given time, 1.4 million people worldwide suffer from
infections acquired in hospitals.” “Ten facts about patient safety”, at www.who.int
• Medical errors and health-care related adverse events occur in
between 8-12% of EU hospitalizations (Conklin, A. Room for improvement; Strong patient
safety systems could limit health, social and economic harms from medical error. RAND Europe, 2009
http://www.rand.org/content/dam/rand/pubs/research_briefs/2009/RAND_RB9472.pdf)
EU citizens’ perceptions of healthcare:
• 50% think there is a risk of patients being harmed by hospital
care and 36% in primary care. (Special Eurobarometer 327, Patient safety and quality of healthcare,
April 2010. European Commission, http://ec.europa.eu/public_opinion/archives/ebs/ebs_327_en.pdf )
8. EPF involvement in Patient Safety
• EC Patient Safety & Quality Working Group
– EC Communication (2008) and
– Council Recommendation (2009)
– Reflection paper on quality
• Advocacy: EU legislation
– Directive on patients’ rights in cross-border healthcare
– Pharmacovigilance
– Falsified medicines
• EU Projects on patient safety
– EUNetPas (2008-2011)
– Joint Action PaSQ (2012-2015)
• Building partnerships and collaboration with WHO, health
professionals, other stakeholders
9. EU legislative framework in patient safety
• Health: EU has limited competence – Article 168 TFEU
– Responsibility for organisation of health systems and delivery of healthcare is
with the Member States
– Principles of subsidiarity & proportionality
– Union action shall complement national policies
“Soft law” & collaboration for exchange of best practices
• Binding legislation (Reg & Dir) to harmonise MS laws in some
areas of exception, e.g. safety of medicines and devices, cross-
border healthcare:
– Article 168(4)(c) TFEU – “measures setting high standards of quality and safety
for medicinal products and devices for medical use”
– Article 114 TFEU – internal market
10. •
Council Recommendation (2009)
2. Empower and inform citizens and patients by:
(a) involving patient organisations and representatives in the development
of policies and programmes on patient safety at all appropriate levels;
(b) disseminating information to patients on:
(i) patient safety standards which are in place;
(ii) risk, safety measures which are in place to reduce or prevent
errors and harm, including best practices, and the right to
informed consent to treatment, to facilitate patient choice and
decision-making;
(iii) complaints procedures and available remedies and redress and
the terms and conditions applicable;
(c) considering the possibilities of development of core competencies in
patient safety namely, the core knowledge, attitudes and skills required to
achieve safer care, for patients.
“
”
11. • Following EUNetPas project (2008-2011)
• Developing permanent collaboration between EU Member
States and stakeholders in the field of quality of care, incl.
patient safety:
– support MS in implementing the Council Recommendation
– enhanced cooperation between MS in the field of quality
– sharing of good practices in patient empowerment and
involvement
• EPF is involved as Associate Partner in all core WPs
• Looking at good organisational practices (GOP) and good
clinical practices (SCP) involving patients
• www.pasq.eu
Joint Action PaSQ (2012-2015)
12. EU Pharmacovigilance legislation
Directive 2010/84 and Regulation 1235/2010
• Rules apply from: 2/12 July 2012
• NEW: 2 patient representatives in EMA PRAC (Pharmacovigilance
Risk Assessment Committee)
Marco Greco / EPF, Albert van der Zejden / IAPO
• NEW: direct patient reporting of ADRs in all EU MS – web + other
forms
• EPF 2012 toolkit on pharmacovigilance: guidance and
recommendations
• Feedback indicates: not much patient engagement, and low
awareness
• Potential for strengthening patients’ involvement & trust
13. Directive 2011/24/EU requires Member States to:
– Make publicly available their safety and quality standards & guidelines;
– cooperate with each other on improving safety and quality standards;
– ensure information on health professionals’ right to practise is given to
other Member States
National Contact Points must provide patients all relevant info
“to enable them to make an informed choice”
EU legal basis for future actions in: safety & quality, eHealth, HTA,
European Reference Networks closer cooperation between
Member States, more transparency, more patient involvement.
Directive on Cross-Border Healthcare
14. • The changing role of patients
•Patients moving from passive recipients of healthcare to active,
involved & politicised actors
•Patient-centredness is a key operating principle of EU health
systems
•But big gap between theory and practice …
•EPF: involvement of patients in patient safety needed both at
individual and collective levels
15. • “Patient safety – everyone’s business”
•1. Individual level:
•Individual patient’s experience of his/her healthcare “journey”
•Rich resource of information about gaps and failures in the
system
•Patients can contribute themselves – by getting actively involved
in their treatment
•Important to support and empower:
Information to patients
Health literacy
Communication with health professionals
Professionals' attitudes
Patient-friendly healthcare environment
16. • “Patient safety – everyone’s business”
•Important caveats:
• Respect patients’ willingness to get involved – or not
• Do not over-estimate patients’ capacity to get involved
• Patients in vulnerable situation – no shifting of burden of
“responsibility” on them
• Patients already observe much – healthcare staff need to
listen more, take their views seriously
•Appropriate support and enabling environment is key
17. 2. Collective level:
•Patient organisations – role in
informing & educating patients
and health professionals
•Effective advocacy through
access to the community
• “Patient safety – everyone’s business”
•Involvement in co-designing healthcare services to make them more
patient-centred & meet real-life needs and preferences of patients
Important to involve patient organisations at policy
level
International, EU and Member States
WHO Patients for Patient Safety programme
18. • EPF survey on Council Recommendation
• Autumn 2012 - 2013
• Exploring perceptions and knowledge of EPF member
organisations
• Focus on awareness of EU recommendations, patient
organisations’ involvement at MS level, assessing priorities
• Ongoing online survey
• Work in progress: interim results!
•
19. • Survey status (November 2013)
Responses received: Responses not received:
Belgium Austria
Bulgaria (2) Denmark
Czech Republic Germany
Cyprus Lithuania
Estonia Luxembourg
France Malta
Greece Portugal
Hungary Finland
Ireland
Italy
Latvia
Netherlands
Poland (2)
Romania
Slovenia
Slovakia
Spain (2)
Sweden
United Kingdom
International organisations (2)
European based organisations (2)
20. • Awareness of the CR
Did you know about the Council Recommendation before this
survey?
Yes
53,8% (14)
No
46,2% (12)
answered question 26
21. • Awareness (2)
If yes, how did you find out about the Council Recommendation?
from the news 6,3% 1
from the European Patients’ Forum 75,0% 12
from an information campaign dedicated to
the Council Recommendation developed in my
country
0,0% 0
information from the organization I represent 18,8% 3
Other (please specify) 18,8% 3
answered question 16
22. • Implementation
Which aspects of the Council Recommendation are in place in your country, as far as you know? (25 answers)
Answer Options Yes No I do not know
national/regional policy/programme on patient safety 15 5 5
designation of a national authority or body responsible for patient safety
15 3 7
patient safety as a priority issue in health policies 12 8 5
development of safer systems, processes and tools 12 3 10
regular update of patient safety standards 8 7 10
involving health professional organisations in patient safety
13 5 7
promotion of safe practices 14 5 6
empowering and informing citizens and patients 7 9 9
creation of blame-free reporting and learning systems on harmful events
7 9 8
education and training of health care workers on patient safety
11 6 7
working with European Commission and other member states to measure
patient safety
7 2 15
working with European Commission and other member states sharing
knowledge and best practices
6 2 16
national research initiatives on patient safety 5 6 13
23. • Patient organisation involvement
24.0%
16.0%
40.0%
44.0%
36.0%
4.0%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
35.0%
40.0%
45.0%
50.0%
Beinginvolvedin
theconsultation
procedures
Beingpartofthe
action
implementation
Developing
information
actionsforthe
patients
Monitoringthe
actionsinthe
interestofpatients
None
Other(please
specify)
What was the role of your organization in realising the
actions (if any)? Please tick as many options as apply:
24. • Information
The 3 main sources of information about patient safety available
in your country:
Mentioned as a source
Not mentioned as source
76.9%
23.10%
1. Internet
42.3%
57.70%
3. Health professionals during face-to-
face consultations
50.0%50.00%
2. Your organsation/ other patient
organisations
25. • Information (2)
4 5
2 1
6
8
9
2
6
6
8
8
21
18
12
0
5
10
15
20
25
30
thePatientsafety
standardsand/oractions
and/orbestpractices
thatexistinyour
country?
theSafetyactionsthat
areinplacetoreduceor
preventmedicalerrors?
patients’rightto
informedconsent?
complaintsprocedures
forpatientsifsomething
goeswrong?
availablecompensation
forpatientsifsomething
goeswrong?
Are patients in your country informed on the following:
Yes
No
I do not know
26. • Priorities
In your opinion which 3 actions out of 13 from the Council
Recommendation are the most important?
national/regional policy/programme
on patient safety
12 3 2 70.58%
patient safety as a priority issue in
health policies
10 3 5 55.55%
empowering and informing citizens
and patients
12 6 1 63.15%
27. “Information, guidance, empowerment, health literacy”
“Knowledge about patients rights and conviction about their enforceability”
“Better communication about p. safety to patients via all media forms”
“More information in the hospitals, in primary care”
“Information on patient safety and the possibility to report on side effects”
“Understandable information and control body/mechanisms”
“Education, seminars”
“A genuine partnership with patient input made from the start”
• Key competences for patients
28. • Key competences for patients
62.5%
16.7%
20.8%
Do patient organisations provide
education for patients in patient
safety?
Yes
No
I do not
know
16.0%
60.0%
24.0%
Does your country provide training
or education for patients in these
skills?
Yes
No
I do not
know
29. • Requests from EPF members
56.0%
44.0%
56.0%
68.0%
52.0%
4.0%
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
Strongeradvocacybypatient
organisations
Betterpromotionatthe
national/regional/locallevel
bythedesignatedauthority
Involvinghealth
professionalsinpromoting
theCouncil
Recommendation
Involvingpatientsand
citizensinpromotingthe
CouncilRecommendation
Organisingan
information/communication
campaign
Other(pleasespecify)
What in your opinion would help the implementation of the
Council Recommendation in your country?
30. • 46% of respondents are unaware of the CR…
• … but many respondents had some role in developing
patient safety information or participating in consultations
• Patient involvement poorly implemented
• EPF by far the most common source of information (75%)
followed by patient organisation at national level (18.8%)
• Patient organisations = important source of capacity-building
for patients
• 56% recommend involving patients and citizens more in
promoting patient safety in their country
• EPF survey shows:
31. • New EU legislation and initiatives = a need and an opportunity to
increase patients’ engagement with PS and patients’ collective
involvement at policy level
• Foster PI and patient-health professional collaboration cultural
shift towards more patient-centred health systems, public trust
• More research needed to define best practices in patient
involvement in PS
• Need to activate EPF membership & create awareness of this
priority area
• Need to formulate a strategy for EPF – objectives & priority actions
• Integrated approach: policy, projects, membership &
communications
• Conclusions & key messages
33. • Patient/public empowerment
•A multi-dimensional process that helps people gain control over
their own lives and increases the capacity of people to act on issues
that they themselves define as important.
•(Luttrell et al. (2009), Understanding and operationalising empowerment. Overseas Development Institute
working paper.)
•A process through which individuals and social groups are able to
express their needs, present their concerns, devise strategies for
involvement in decision-making, and take political, social, and
cultural action to meet those needs.
• (Deepening our Understanding of Quality improvement in Europe; http://www.duque.eu/)
• Elements: Information – Informed consent – feedback loop –
enabling and supportive healthcare environment – health
professional’s training
“
“
”
”
34. • Patient/public involvement
•The extent to which patients and their families or caregivers,
whenever appropriate, participate in decisions related to their
condition (e.g. through shared decision-making, self-management)
and contribute to organisational learning through their specific
experience as patients (e.g. patient reporting of adverse events or
participation in root cause analysis related to their care).
•Collective patient/public involvement is the extent to which
patients and citizens, through their representative organisations,
contribute to shaping the health care system through involvement
in health care policy-making, organisation and delivery.
•(European Patients Forum for PaSQ, adapted from the Value+ project: http://www.eu-patient.eu/Initatives-
Policy/Projects/EPF-led-EU-Projects/ValuePlus/
•Levels: Consultation Collaboration User-Led
“
”